Blog

The initial cohort of the Primary Care First model went live on Jan. 1.  Cohort 1, represented by 847 practices and 14 payer partners, is offered in 26 regions across the country. Over the six-year PCF demonstration period, CMS will test whether advanced primary care practices can improve patient experience and quality, reduce total cost […]

Read More...

DataGen has completed its analysis of enacted Medicare cuts, the results of which are shared here. Please note that this analysis is intended for advocacy purposes only and should be used as an indication of the extent to which hospital providers nationwide have been impacted by existing Medicare provider payment cuts. These cuts were enacted […]

Read More...

It’s been a year: a year since the first lockdowns and a year since the landscape of healthcare in the U.S. changed forever. While we’re still evaluating the impacts of the pandemic on healthcare policy, we now have seen enough data to assess the effect of the past year on alternative payments models and how […]

Read More...

On Jan. 19, the Office of Management and Budget requested public comment on recommendations for changes to OMB’s metropolitan and micropolitan statistical area standards. The recommendations, made by the Metropolitan and Micropolitan Statistical Area Standards Review Committee, included increasing the minimum urban area population to qualify a metropolitan statistical area from 50,000 to 100,000. The […]

Read More...

In November 2020, CMS announced a nationwide model that aims to reduce spending on Medicare Part B drug payments without impacting the quality of care. Called the Most Favored Nation model, the program endeavors to lower prescription drug costs by “paying no more for 50 high-cost Medicare Part B drugs and biologicals than the lowest […]

Read More...

Background:  After months of anticipation, CMS is planning to go forward with the mandatory Radiation Oncology Model. This bundled payment model, which was first announced in a proposed rule on July 10, 2019, with an anticipated start in January or April 2020, is notable for being one of the first mandatory models the industry has […]

Read More...

The COVID-19 public health emergency has resulted in numerous federal policy and program changes. Comprehensive Care for Joint Replacement program participants need to be aware of and prepared for several program changes in one of the most recent, CMS’ Additional Policy and Regulatory Revisions in Response to the COVID-19 PHE, released Oct. 28. First, the […]

Read More...

The COVID-19 pandemic has impacted every aspect of our healthcare system. That’s true for participants in the Oncology Care Model and Bundled Payments for Care Improvement Advanced programs. Organizations in these programs had to make important decisions regarding the overlap of their program performance periods with the COVID-19 public health emergency. Several trends have begun […]

Read More...

Six months after the initial lockdowns, COVID-19 continues to exert its grip on the country and the world. Amid this unprecedented crisis, the economy and human behavior are changing rapidly — and that holds true for the healthcare industry as well. Here are some updates from the past month that reflect an industry in the […]

Read More...

In response to the COVID-19 pandemic, CMS has implemented several policy amendments and changes to value-based care program methodologies. In June, CMS released new COVID-19-related payment methodology and data reporting flexibilities for Oncology Care Model participants impacting performance periods 7-9, along with establishing two new voluntary performance periods in 2021. The deadline for electing to […]

Read More...